Archive | FDA Drug Advisory RSS feed for this section
Heart defects central in lawsuit against Zoloft maker
Heart defects are among the main health problems blamed on Zoloft in a growing lawsuit against the makers of the antidepressant. The lawsuit is based on evidence that the use of Zoloft during pregnancy led to numerous birth defects in babies across the country. The risk appears to be greatest when Zoloft was taken during [...]
Continue reading...FDA warns of lower cognitive functioning with Valproate
30. June 2011
The FDA has reported that the children of mothers who took the drug Valproate during pregnancy appear to have lower levels of cognitive functioning than other children. Valproate drugs include the following: divalproex sodium (Depakote, Depakote ER, Depakote CP), valproate sodium (Depacon), valproic acid (Stavzor, Depakene), and the generic versions of these drugs. Valproate is [...]
Continue reading...Lawsuits for Zoloft birth defects: atrial and ventricular septal defects
24. June 2011
After investigation, experts have noted a link between certain birth defects and ingestion of the antidepressant Zoloft during pregnancy. Zoloft, one of a group of drugs known as selective serotonin reuptake inhibitors (SSRIs), is often prescribed for depression, obsessive-compulsive disorder, and various anxiety and panic disorders. One of the primary classes of defects experts have [...]
Continue reading...In lawsuit, experts link Zoloft to tetralogy of fallot
20. June 2011
In a lawsuit against the makers of the drug Zoloft, experts are citing links between ingestion of the drug and birth defects involving the heart. Among other conditions, infants whose mothers took Zoloft while pregnant show a higher risk of giving birth to children with tetralogy of fallot. Tetralogy of fallot is a combination of [...]
Continue reading...FDA warns of heart attack risk with Chantix
20. June 2011
The Food and Drug Administration has added a warning for smokers who use the drug Chantix to help them quit. The FDA said Thursday that Chantix, manufactured by Pfizer Inc., increases the chances that users with cardiovascular disease will suffer heart attacks. The FDA cited a trial of 700 smokers, some of whom were given [...]
Continue reading...Topamax causes oral birth defects in babies
4. March 2011
Topamax epilepsy drug also used to help prevent migraines can increase the risk for oral birth defects in babies born to women taking the medication. According to FDA, new data shows expecting mothers taking the Topamax drug, sold generically and as brand name Johnson & Johnson’s Topamax, are about 20 times more likely to have [...]
Continue reading...Propoxyphene worst drug in history
10. February 2011
An estimated 10 million patients have used the pain reliever propoxyphene and were sent scrambling to doctors’ offices when it was recently pulled from the market. Many physicians are still dealing with the aftermath of the product, first approved by the US Food and Drug Administration (FDA) in 1957. “Propoxyphene is the worst drug in [...]
Continue reading...FDA pulls propoxyphene off the market
19. November 2010
The pharmaceutical company that makes the prescription pain medications Darvon and Darvocet has agreed to withdraw the drugs from the U.S. market at the request of the U.S. Food and Drug Administration, the FDA said Friday. The FDA says the drug, propoxyphene, puts patients at risk of potentially serious or fatal heart rhythm abnormalities. Since [...]
Continue reading...Avandia restricted to limited Type 2 diabetes patients
23. September 2010
The Food and Drug Administration announced Thursday that access to the diabetes drug Avandia will be restricted to patients with Type 2 diabetes whose condition cannot be controlled with other medications. Also Thursday, the European Medicines Agency recommended that Avandia be taken off the market. The EMA is Europe’s counterpart to the U.S. Food and [...]
Continue reading...FDA issues warning on drugs used in MRI medical imaging scans
11. September 2010
Federal health regulators are warning doctors that a class of injectable drugs used in MRI medical imaging scans can cause a rare and sometimes fatal condition in patients with kidney disease. The Food and Drug Administration said Thursday it is adding its strongest warning label to imaging agents that contain the chemical gadolinium, highlighting the [...]
Continue reading...
- Risperdal (Resperidone)
- FDA issues warning on Advair, Symbicort, Foradil and Serevent
- Benzoyl Peroxide Acne Cream 10% Contained Burkholderia Cepacia Bacteria
- Crestor Linked to Rhabdomyolysis (Fatal Muscle Disease)
- Merck’s Vioxx $4.85 billion payouts to begin in August
- Zoloft lawsuit
- Infants' Mylicon Gas Relief Dye Free Drops Recalled
- Fluoroquinolone Antimicrobial Drugs
- Arthritis Drug Vioxx Recalled
- Tysabri monotherapy and progressive multifocal leukoencephalopathy
- None found
- Yaz associated with a higher risk for blood clots
- FDA Issues warning on counterfeit Avastin
- Pfizer birth control pills may not prevent pregnancy
- Adcetris brain infection death
- FDA warning on Multaq and Increased Risk of Death
- SSRI and Potential Risk of Persistent Pulmonary Hypertension
- Serious Complications Associated with Vaginal Mesh devices
- Actos Lawsuit
- Infant heart defect risks increase with SSRIs
- Birth defects more likely with SSRI use
2. July 2011
0 Comments